why choose us

Clinical Trials Search

Showing 10,000 of 132,963 result(s)
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Status: Completed

Condition: Cancer

Interventions: Genetically modified herpes simplex type 1 virus

Date: 2023-07-24

MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial

Status: Completed

Condition: Locally Advanced Cervical Carcinoma

Interventions:

Date: 2023-07-24

Optimizing the Impact of the Healthy School Recognized Campus Program on Youth's CVD Risk Factors

Status: ACTIVE_NOT_RECRUITING

Condition: Cardiovascular Diseases

Interventions: Schools in this group will participate in meetings and discussion boards and receive newsletters to help with program implementation.

Date: 2023-07-24

Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and;or Refractory Multiple Myeloma

Status: COMPLETED

Condition: Multiple Myeloma

Interventions: Belantamab Mafodotin - blmf (BLENREP) given for the treatment of relapsed and;or refractory multiple myeloma.

Date: 2023-07-24

Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in Brazil

Status: NOT_YET_RECRUITING

Condition: Silicosis

Interventions: Participants will freely elect to be in either the intervention group.
Individuals in the experimental group will receive the intervention while

Date: 2023-07-24

Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma

Status: NOT_YET_RECRUITING

Condition: T Cell Lymphoma

Interventions: Mogamulizumab is a humanized monoclonal antibody directed against C-C chemokine receptor 4 (CCR4) with potential anti-inflammatory and antineoplastic

Date: 2023-07-24

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

Status: Completed

Condition: Breast Cancer

Interventions: Takes place at single time point.

Date: 2023-07-24

Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

Status: Completed

Condition: Renal Cancer

Interventions: Axitinib is a potent oral, vascular endothelial growth factor, c-kit and platelet derived growth factor inhibitor.

Date: 2023-07-24

The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function

Status: Completed

Condition: Obesity

Interventions: Empagliflozin is an FDA-approved SGLT2 inhibitor used for the treatment of type 2 diabetes, with off-label use for diabetic kidney disease and for hea

Date: 2023-07-24

Does Mirabegron Increase the Body Heat Generated by the Nervous System

Status: Completed

Condition: Thermoregulation

Interventions: Participants take 4x 25mg Myrbetriq 25Mg Extended-Release Tablet orally.

Date: 2023-07-24